OMER : Summary for Omeros Corporation - Yahoo Finance

U.S. Markets open in 5 hrs 10 mins

Omeros Corporation (OMER)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
10.56-0.35 (-3.21%)
At close: 4:00 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close10.91
Bid10.00 x 1000
Ask10.75 x 100
Day's Range10.48 - 11.41
52 Week Range7.20 - 16.80
Avg. Volume695,631
Market Cap453.19M
PE Ratio (TTM)-6.18
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Why Omeros Corporation Stock Popped 47.9% in November
    Motley Fool12 hours ago

    Why Omeros Corporation Stock Popped 47.9% in November

    Ambitious goals appear within reach after a positive earnings report.

  • Capital Cube16 hours ago

    ETFs with exposure to Omeros Corp. : December 5, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Omeros Corp. Here are 5 ETFs with the largest exposure to OMER-US. Comparing the performance and risk of Omeros Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Business Wire21 hours ago

    Omeros’ Proprietary Orphan GPCR Program Delivers New Target and Approach in Cancer Immunotherapy

    Omeros Corporation today announced that its small-molecule inhibitors against GPR174, an orphan G protein-coupled receptor narrowly expressed in immune cells and linked to cancers, substantially and statistically significantly boost levels of cytokines and reduce the population of a subset of T cells known as regulatory T cells , both activities known to be important in cancer immunotherapy.